Linda Rubinstein Email & Phone Number

Palo Alto, Ca, Us

FLG is engaged by companies, their boards and investors to provide CFO leadership on a permanent, full time, part time, or project basis, from A-round private companies to billion-dollar public ones. We work with venture-backed companies, firms owned by private equity investors and public companies, across all sectors. My focus is life sciences, including biotechnology and molecular diagnostics, as well as healthcare in general. I'm also interested in greentech. I work with both public and private companies and have run IPO preparation, M&A and dual track processes.

Redwood City, California, Us

Publicly traded clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases

San Diego, California, Us

Publicly traded provider of molecular diagnostic assays and services, including CNSide, Biocept's cell-based and cell-free CSF liquid biopsy test.

Menlo Park, Us

Clinical-stage biopharmaceutical company aiming to transform the discovery of oncology, autoimmune disorder, and infectious disease therapeutics by employing its versatile PEPTIKINE (synthetic cytokine) drug discovery platform

San Carlos, California, Us

Venture-funded, clinical-stage biotech company developing antibody therapeutics to activate immunity in cancer.

South San Francisco, California, Us

Publicly traded, clinical-stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases.

Los Altos, Ca, Us

Advised on execution of IPO for this Phase 3 biopharmaceutical company targeting difficult-to-treat solid tumors, initially pancreatic cancer and hilar cholangiocarcinoma, via its proprietary Trans-Arterial Micro-Perfusion (RenovoTAMP) therapy platform.

Dublin, 11, Ie

Venture-funded, clinical-stage biotech company developing an orally dosed calcineurin inhibitor for ulcerative colitis (currently in Phase 2b) and advancing its proprietary SmPill® formulation technology.

Calabasas, Ca, Us

Venture-backed, clinical-stage biotech company with drug candidate pipeline in orphan and neurodegenerative diseases based on its blood brain barrier technology. Acquired by JCR Pharmaceuticals April 2020.

Interim CFO at publicly traded biotech company with multiple clinical-stage immuno-oncology programs.

South San Francisco, California, Us

Venture-funded biotech company developing small molecule therapeutics for autoimmunity and cancer. Helped to prepare for IPO including completing PCAOB audit uplift and filing initial confidential S-1.

Precision microbiome engineering company employing genomics and selective deletion strategies with initial application in bovine mastitis.

Clinical-stage biotech company addressing lipid peroxidation and mitochondrial ioss of function in multiple orphan indications and in major diseases including Alzheimer’s, Parkinson’s and retinopathies.

Venture-backed biotechnology company developing novel therapeutics to address allergic inflammation, allergy and orphan diseases.

Venture-backed biotechnology company developing novel therapies that selectively target the Complement pathway of the immune system.

Solid-state and internally calibrated pH sensing for process and other in-line applications.

Specialty vaccine company addressing vaccines for travel and biodefense, with a double bottom line mission. I executed financings totaling up to $62 million, was instrumental in the acquisition of vaccine assets from J&J / Crucell and designed the company's international tax structure.

Biotechnology company developing novel therapies for neurodegenerative disease, including PSP and Alzheimer's, which was acquired by Bristol-Myers Squibb in 2014.

Cloud computing for genome analysis for research and diagnostics, which was acquired by QIAGEN in 2013.

Pleasanton, California, Us

SaaS for customer experience management used by hundreds of the world’s leading brands.

Princeton, New Jersey, Us

San Diego, Ca, Us

Financial and strategic consultants to the biotechnology and medical device industries:• Interim and long-term consulting CFO• Plan and execute equity and debt financings• Corporate development, including M&A• Create business plans

San Diego, Ca, Us

Acquired by Illumina, Inc.

Washington, Dc, Us

San Carlos, California, Us

South San Francisco, California, Us

Us

• 1996-2001: Health care investment banking (San Francisco, CA)• 1993-1995: Industrial group investment banking (New York, NY)

New York, Ny, Us